CTNM
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Contineum Therapeutics reported Phase 2 results for JNJ-5120/PIPE-307 in major depressive disorderSep 15, 2026
- Contineum Therapeutics published the discovery of PIPE-791 in the Journal of Medicinal ChemistryJul 1, 2026
- Contineum Therapeutics reported positive topline results from the Phase 1b PIPE-791 trial in chronic painMay 1, 2026
- Contineum Therapeutics reports positive topline data from Phase 1b positron emission tomography (PET) trial of PIPE-791Sep 18, 2025
- Contineum Therapeutics provides update on Phase 1b PET trial of PIPE-791Jun 25, 2025